BG
Bunge Global
$109.29
▲ 0.3%Updated Aug 7, 11:30 AM ET
BG at a glance — five pillars scored 0–100 from real filed financials.
Overall: Neutral · 47/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 31.6% over the last 12 months
Market Cap
$20.66B
P/E
31.19x
Forward P/E (est.)
44.56x
ROE
4.7%
Revenue Growth
56.9%
EPS Growth
-45.8%
Profit Margin
0.9%
FCF Yield
13.6%
Debt / Equity
0.9x
ROIC
—
Interest Coverage
—
Current Ratio
1.6x
Dividend Yield
2.3%
Implied Growth (rev. DCF)
—
Rating Score
47/100
Bunge Global (BG) is a large-cap company in the Agricultural Products & Services industry, part of the Consumer Staples sector of the S&P 500, with a market value around $20.66B.
In its latest reported year it generated about $16.94B in revenue and $816.00M in net profit.
Our model rates BG Neutral (47/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (5 years of history).
The numbers don't show a durable competitive advantage — margins, growth, or returns on capital have been unstable or thin. Great returns are still possible; they just aren't protected.
23.0% average over the last 3 years
±3.2 pts around 21.3% across 5 years
grew in 2 of the last 4 year-over-year periods
positive in 2 of 5 years
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what BG's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. BG trades near $109.29, around its 50-day average ($121.79) and 200-day average ($108.49). Price tangled in its moving averages means there is no clear trend — the stock is ranging.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 20 it is oversold — selling has been heavy and a bounce is possible.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. BG's is $3.68 (~3.4% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month BG found buyers near $104.12 (support) and sellers near $132.91 (resistance); its 52-week range is $71.60–$134.87. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 1.0× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
0.2%
Revenue moved from $16.81B in 2021 to $16.94B in 2025, a 0.2% compound annual growth rate. The most recent year grew a strong 56.9% year over year. Consistent top-line growth is one sign of healthy demand.
Gross Margin
20.1%
Operating Margin
1.6%
Net Margin
4.8%
ROE
4.7%
Bunge Global keeps about 0.9% of each sales dollar as net profit, with a 20.1% gross margin and 1.6% operating margin. Return on equity is 4.7%. Thin margins leave less cushion if costs rise.
Total Debt
$11.31B
Net Debt
$10.47B
Net Debt / EBITDA
—
Debt / Equity
0.9x
Leverage: debt-to-equity is 0.9x, with a current ratio of 1.6x. That is a moderate, manageable debt load for most businesses. It carries roughly $11.31B of total debt against $839.00M of cash.
Operating CF
$844.00M
Free Cash Flow
-$879.00M
FCF Margin
-5.2%
In the latest year Bunge Global produced about $844.00M of operating cash flow but negative free cash flow as it invested heavily. That is a free-cash-flow yield of about 13.6% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
Coverage is weak, the payout was cut recently, or it's being financed rather than earned — treat the current yield as fragile.
Dividend yield
2.3%
Per share (latest FY)
$2.80
Total paid (latest FY)
$459.00M
History on record
5 years
free cash flow was negative in the latest year — the dividend is being financed
56% of net income paid out
total dividends increased 1 year in a row
no cuts in the last 5 years on record
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
31.19x
P/S
0.33x
P/B
0.99x
EV / EBITDA
—
BG trades at 31.2x trailing earnings (about 44.6x on estimated forward earnings), 0.3x sales, and 1.0x book value. That is a premium multiple that needs growth to justify it.
Where BG sits versus its Consumer Staples sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 48 Consumer Staples companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How BG stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.
In the Consumer Staples sector (74 S&P 500 companies), BG ranks #25 of 74 by our overall rating. It trades at a premium versus the sector on earnings (31.2x P/E vs. 22x median) with a lower return on equity (4.7% vs. 18.1%) and faster revenue growth (56.9% vs. 3.4%).
P/E vs sector
31.2x
median 22x
ROE vs sector
4.7%
median 18.1%
Growth vs sector
56.9%
median 3.4%
Sector rank
#25
of 74 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 74 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $109.29 today · expected CAGR 38% – 52%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $24.57B | $35.62B | $51.66B | $74.90B | $108.61B |
| Net income | $1.23B | $1.78B | $2.58B | $3.75B | $5.43B |
| EPS | $6.50 | $9.42 | $13.67 | $19.82 | $28.73 |
| Share price (low) | $123.50 | $179.07 | $259.65 | $376.50 | $545.92 |
| Share price (high) | $201.50 | $292.17 | $423.65 | $614.29 | $890.72 |
| CAGR (low–high) | 13% / 84% | 28% / 64% | 33% / 57% | 36% / 54% | 38% / 52% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for BG:
- Revenue is growing 56.9% a year, a sign of real demand.
- Healthy free-cash-flow yield (~13.6%) funds buybacks and dividends.
- Pays a 2.3% dividend on top of any price gains.
The case against BG:
- Thin net margins (0.9%) leave little room for error.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Valuation risk — at 31.2x earnings, disappointing results could compress the multiple.
Margin risk — thin profitability (0.9%) is vulnerable to cost or pricing pressure.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Bunge Global is a large-cap consumer staples business still growing nicely, with modest profitability, and a heavier debt load to watch. It trades at 31.2x earnings, which our model scores Neutral (47/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 20 Wall Street analysts covering BG recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Latest SEC Filings
BG's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
BG — frequently asked questions
Is BG a good stock to buy?
We don't give buy or sell advice. Our model rates Bunge Global Neutral (47/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is BG's rating on The Stocks School?
Bunge Global currently scores 47/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does BG's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Bunge Global's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for BG calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this BG analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell BG. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.